Technology in Cancer Research and Treatment This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

HBB as a Novel Biomarker for the Diagnosis and Monitoring of Lung Cancer Regulates Cell Proliferation via ERK1/2 Pathway
Conclusion: HBB can serve as a novel biomarker for the diagnosis and monitoring of lung cancer, regulating cell proliferation via the ERK1/2 pathway and playing a pivotal role in the oncogenesis and progression of the disease.PMID:38679728 | PMC:PMC11057351 | DOI:10.1177/15330338241249032 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 28, 2024 Category: Cancer & Oncology Authors: Xinxin Xu Hua Cai Jingjing Peng Hongli Liu Fuying Chu Source Type: research

HBB as a Novel Biomarker for the Diagnosis and Monitoring of Lung Cancer Regulates Cell Proliferation via ERK1/2 Pathway
Conclusion: HBB can serve as a novel biomarker for the diagnosis and monitoring of lung cancer, regulating cell proliferation via the ERK1/2 pathway and playing a pivotal role in the oncogenesis and progression of the disease.PMID:38679728 | DOI:10.1177/15330338241249032 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 28, 2024 Category: Cancer & Oncology Authors: Xinxin Xu Hua Cai Jingjing Peng Hongli Liu Fuying Chu Source Type: research

Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging
CONCLUSION: The CT radiomic model can be used to predict the BCLC stage of early-stage and intermediate-stage HCC.PMID:38660703 | PMC:PMC11044781 | DOI:10.1177/15330338241245943 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 25, 2024 Category: Cancer & Oncology Authors: Han Dong Lu Yang Duan Shaofeng Guo Lili Source Type: research

Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging
CONCLUSION: The CT radiomic model can be used to predict the BCLC stage of early-stage and intermediate-stage HCC.PMID:38660703 | DOI:10.1177/15330338241245943 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 25, 2024 Category: Cancer & Oncology Authors: Han Dong Lu Yang Duan Shaofeng Guo Lili Source Type: research

Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer
Conclusion: Our data suggests that the use of anti-angiogenic drugs may not exacerbate COVID-19 severity in NSCLC patients, indicating their potential safe application even during the pandemic period.PMID:38656242 | DOI:10.1177/15330338241248573 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 24, 2024 Category: Cancer & Oncology Authors: Sujuan Peng Hongxiang Huang Jinhong Chen Xinjing Ding Xie Zhu Yangyang Liu Li Chen Zhihui Lu Source Type: research

Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth
Conclusion: Interference with SLC3A2 inhibited the growth of BLCA cells and the polarization of tumor-associated macrophages by promoting ferroptosis in BLCA cells.PMID:38656249 | DOI:10.1177/15330338241246649 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 24, 2024 Category: Cancer & Oncology Authors: Peishan Wu Lingna Zhao Guangqi Kong Bo Song Source Type: research

The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241239188. doi: 10.1177/15330338241239188.ABSTRACTGlobally, hepatic cancer ranks fourth in terms of cancer-related mortality and is the sixth most frequent kind of cancer. Around 80% of liver cancers are hepatocellular carcinomas (HCC), which are the leading cause of cancer death. It is well known that HCC may develop resistance to the available chemotherapy treatments very fast. One of the biggest obstacles in providing cancer patients with appropriate care is drug resistance. According to reports, more than 90% of cancer-specific fatalities are caused by treatment resista...
Source: Technology in Cancer Research and Treatment - April 18, 2024 Category: Cancer & Oncology Authors: Ali Tavakoli Pirzaman Ali Alishah Bahareh Babajani Pouyan Ebrahimi Seyyed Ali Sheikhi Farhad Moosaei Amirhossein Salarfar Shahrbanoo Doostmohamadian Sohrab Kazemi Source Type: research

Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions
CONCLUSION: The combination of age, prostate-specific antigen density, lesion volume, apparent diffusion coefficient, and digital rectal examination presented a higher diagnostic value for clinically significant prostate cancer than any single parameter in patients with Prostate Imaging Reporting and Data System 3 lesions. Systematic biopsy proved crucial for biopsy-naive patients with Prostate Imaging Reporting and Data System 3 lesions and should not be omitted.PMID:38629205 | PMC:PMC11025422 | DOI:10.1177/15330338241246636 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 17, 2024 Category: Cancer & Oncology Authors: Zhiyu Zhang Can Hu Yuxin Lin Ouyang Song Dongkui Gong Xuefeng Zhang Nan Wang Source Type: research

Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions
CONCLUSION: The combination of age, prostate-specific antigen density, lesion volume, apparent diffusion coefficient, and digital rectal examination presented a higher diagnostic value for clinically significant prostate cancer than any single parameter in patients with Prostate Imaging Reporting and Data System 3 lesions. Systematic biopsy proved crucial for biopsy-naive patients with Prostate Imaging Reporting and Data System 3 lesions and should not be omitted.PMID:38629205 | DOI:10.1177/15330338241246636 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 17, 2024 Category: Cancer & Oncology Authors: Zhiyu Zhang Can Hu Yuxin Lin Ouyang Song Dongkui Gong Xuefeng Zhang Nan Wang Source Type: research

Corrigendum
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241241784. doi: 10.1177/15330338241241784.NO ABSTRACTPMID:38623700 | DOI:10.1177/15330338241241784 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 16, 2024 Category: Cancer & Oncology Source Type: research

Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer
Conclusion: The new immune molecule HHLA2 may be an ideal clinical biomarker for predicting SCLC progression and could serve as a new immunotherapy target in SCLC.PMID:38613340 | PMC:PMC11015749 | DOI:10.1177/15330338241240683 (Source: Technology in Cancer Research and Treatment)
Source: Technology in Cancer Research and Treatment - April 13, 2024 Category: Cancer & Oncology Authors: Xiuqin Zhang Yan Qin Xu Chen Mengrui Xiong Song Shu Source Type: research